Geisel School of Medicine Board of Overseers
Jeffrey A. Cohen, MD
Dr. Cohen received his MD from the University of Oklahoma, College of Medicine in Oklahoma City, OK in 1977. He completed his residency in Neurology and Medicine at Mount Sinai Hospital in New York, NY in 1981. He went on to complete a Clinical and Research Fellowship in Neurology with a focus on Neuromuscular Disease and Neurophysiology at Massachusetts General Hospital, Boston, MA in 1982, followed by a fellowship in Peripheral Nerve Disease at the Mayo Clinic in Rochester, MN in 1986. Before joining Dartmouth-Hitchcock, Dr. Cohen served as an attending neurologist at University Hospital, Denver, CO and Saint Joseph Hospital, Denver, CO.
Jeff joined the faculty at Dartmouth in 2000. He has been the Chair of the Department of Neurology since 2010 and Director of the DHMC ALS Clinic since 2002. In 2003, he established and became the director of the Clinical Neurophysiology and Fellowship Program. He has been a mentor as part of the Dartmouth-Hitchcock Leadership Preventative Medicine Residency Program since 2003. In 2006, he collaborated with a Dartmouth student to form Co-SIGN (College Student Interest Group in Neurology), which received funding from the American Academy of Neurology. Jeff has been a course co-director for SBM neurosciences and regularly teaches as part of the medical student lecture series and Neurology small group sessions. He teaches students, residents, and fellows in the clinic, the inpatient unit, and the classroom. He has published on diabetic neuropathy and neuromuscular disorders. He co-authored a popular Oxford University Press book on Neuromuscular Disorders.
Jeff is an elected member of the Geisel Academy of Master Educators. In 2014, he was recognized as the Burton Sandok Visiting Professor of Neurology at the Mayo Clinic. He is a Fellow of the American Academy of Neurology and the American College of Physicians. He also served as a member of the FDA Peripheral and Central Nervous System Advisory Panel. He is a reviewer for a number of journals and has served on grant review committees both internally (as scientific chair for the Hitchcock Foundation) and externally, including NeuroNEXT, FDA and the British Medical Research Council. He has initiated the Diamond Grant Program to advance neuroscience research using Neurology’s $6 million Diamond Endowment.